Benzinga | Aug 17, 2021 08:26AM EDT

Qualigen Therapeutics Q2 EPS $(0.18) Up From $(0.41) YoY, Sales $1.10M Up From $837.71K YoY

Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.18) per share. This is a 56.1 percent increase over losses of $(0.41) per share from the same period last year. The company reported $1.10 million in sales this quarter. This is a 31.31 percent increase over sales of $837.71 thousand the same period last year.